ArticleThe Journal of cell biology1995

Targeted disruption of CD44 in MDAY-D2 lymphosarcoma cells has no effect on subcutaneous growth or metastatic capacity.

M H Driessens et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.